BNP Paribas Financial Markets’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $237K | Sell |
|
|||||
|
2025
Q2 | $297K | Sell |
|
|||||
|
2025
Q1 | $263K | Sell |
|
|||||
|
2024
Q4 | $409K | Buy |
|
|||||
|
2024
Q3 | $367K | Buy |
|
|||||
|
2024
Q2 | $451K | Buy |
|
|||||
|
2024
Q1 | $431K | Sell |
|
|||||
|
2023
Q4 | $465K | Sell |
|
|||||
|
2023
Q3 | $619K | Buy |
|
|||||
|
2023
Q2 | $1M | Buy |
|
|||||
|
2023
Q1 | $937K | Sell |
|
|||||
|
2022
Q4 | $1.09M | Sell |
|
|||||
|
2022
Q3 | $1.37M | Buy |
|
|||||
|
2022
Q2 | $293K | Sell |
|
|||||
|
2022
Q1 | $601K | Sell |
|
|||||
|
2021
Q4 | $1.85M | Buy |
|
|||||
|
2021
Q3 | $1.07M | Buy |
|
|||||
|
2021
Q2 | $330K | Sell |
|
|||||
|
2021
Q1 | $386K | Buy |
|
|||||
|
2020
Q4 | $127K | Sell |
|
|||||
|
2020
Q3 | $222K | Sell |
|
|||||
|
2020
Q2 | $1.18M | Sell |
|
|||||
|
2020
Q1 | $1.73M | Buy |
|
|||||
|
2019
Q4 | $230K | Buy |
|
|||||
|
2019
Q3 | $162K | Buy |
|
|||||
|
2019
Q2 | $158K | Sell |
|
|||||
|
2019
Q1 | $334K | Buy |
|
|||||
|
2018
Q4 | $425 | Sell |
|
|||||
|
2018
Q3 | $47.3K | Sell |
|
|||||
|
2018
Q2 | $949K | Sell |
|
|||||
|
2018
Q1 | $1.02M | Sell |
|
|||||
|
2017
Q4 | $1.2M | Buy |
|
|||||
|
2017
Q3 | $349K | Buy |
|
|||||
|
2017
Q2 | $159K | Buy |
|
|||||
|
2017
Q1 | $83.4K | Sell |
|
|||||
|
2016
Q4 | $99.7K | Buy |
|
|||||
|
2016
Q3 | $59K | Sell |
|
|||||
|
2016
Q2 | $97.4K | Buy |
|
|||||
|
2016
Q1 | $60.6K | Sell |
|
|||||
|
2015
Q4 | $125K | Buy |
|
|||||
|
2015
Q3 | $129K | Buy |
|
|||||
|
2015
Q2 | $59.9K | Buy |
|
|||||
|
2015
Q1 | $7.62K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $32.1K | Buy |
|
|||||
|
2014
Q2 | $1.46K | Buy |
|